Nextomabs

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameNextomabs
Drug Alias Namemonoclonal antibody program (Lpath)mAB program (Lpath)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationAutoimmune DiseasesEye Diseases +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesApollo Endosurgery Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApollo Endosurgery Inc
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune DiseasesEye Diseases +[7] 

Other Information

ATC CodeN/A
Related LinksN/A